Tempus

@TempusLabs

Tempus is a technology company that enables physicians to deliver personalized cancer care.

Vrijeme pridruživanja: listopad 2015.

Tweetovi

Blokirali ste korisnika/cu @TempusLabs

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @TempusLabs

  1. prije 23 sata

    Our collaboration with and Epic seamlessly integrates our genomic testing directly into an EMR as structured variant results, and we are thrilled to bring this new functionality to the market and providers

    Poništi
  2. proslijedio/la je Tweet
    30. sij

    What sets project management executives , , and apart? They find otherwise-unseen areas of opportunity in their space.

    Poništi
  3. 24. sij

    An incredible few days at , including an appearance by our own Mark Oldroyd on a testing panel w/ 's , Becky Nagy of , Shari Brown of , and of .

    Poništi
  4. 20. sij

    A big welcome to and as they join our team!

    Poništi
  5. 8. sij

    Looking forward to joining our industry colleagues at next week as our CEO presents an overview of Tempus and the practical application of in healthcare.

    Poništi
  6. 3. sij

    Fortunate to be among such good company in 's list of startups revolutionizing in 2020

    Poništi
  7. 12. pro 2019.

    Today, we announced our collaboration with - leveraging our broad-panel data to automate the prior authorization approval process, expedite start time for patients' therapy, and reduce the total cost of care. Read more here:

    Poništi
  8. proslijedio/la je Tweet
    3. pro 2019.
    , , i još njih 7
    Poništi
  9. 2. pro 2019.

    We are so proud to be a part of 's pilot program, joining industry leaders to advance the field.

    Poništi
  10. 21. stu 2019.

    SVP of Research joined ' and of for a panel that broke down the hype behind medical breakthroughs at

    Poništi
  11. 21. stu 2019.

    Today (and every day), we honor 's work in driving research and supporting patients

    Poništi
  12. 20. stu 2019.

    We are so proud of Lauren Silvis for being included in first-ever DC Healthcare Power Players List. Much deserved!

    Poništi
  13. proslijedio/la je Tweet
    15. stu 2019.

    We had an amazing time with everyone last night at ! Congratulations winner and Inno Blazers, inspire us everyday! 🔥🔥🔥

    Poništi
  14. proslijedio/la je Tweet
    12. stu 2019.

    can potentially teach us things that we’ve been maybe misinterpreting for decades” -Brandon Fornwalt, Dir. of the AI Lab for the Steele Institute for Health Innovation at ⁦

    Poništi
  15. proslijedio/la je Tweet

    . + ' speaks to the importance of data in curing diseases: The whole point of data is to have enough of it to actually answer the questions that cure diseases

    Poništi
  16. 6. stu 2019.

    The Abstract ID P103 poster shows how our xT assay can be utilized to detect loss of heterozygosity in human leukocyte antigen - which plays a role in the ability of a patient's immune system to recognize and attack the tumor and serves as a biomarker for

    Poništi
  17. 6. stu 2019.

    The Abstract ID P15 poster outlines how we use our non-invasive, xF liquid biopsy assay to determine MSI status of tumors in order to identify patients who are candidates for

    Poništi
  18. 6. stu 2019.

    Come find us at this week! We are presenting two posters on Friday and sharing a quick preview with you today.

    Poništi
  19. proslijedio/la je Tweet

    I’m honored to be joining the board of , one of the many companies in ’s portfolio that are changing patients’ lives; and to be supporting Tempus’ mission to empower patients and providers, and make cancer care more informed and personal

    Poništi
  20. 29. lis 2019.

    Today, we announced that  has joined our Board of Directors. His expertise and vision for leveraging technology to improve makes him an invaluable advisor as we bring the power and promise of to

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·